The technique of delivery of peri-operative analgesia does not affect the rehabilitation or outcomes following total knee arthroplasty by McDonald, D. A. et al.
Peri-operative analgesic method does not affect rehabilitation outcomes following total
knee arthroplasty
McDonald, D. A.; Deakin, A.H.; Ellis, B.M.; Robb, Y.; Howe, T.E.; Kinninmonth, A.W.G.; Scott,
N.B.
Published in:







Link to publication in ResearchOnline
Citation for published version (Harvard):
McDonald, DA, Deakin, AH, Ellis, BM, Robb, Y, Howe, TE, Kinninmonth, AWG & Scott, NB 2016, 'Peri-operative
analgesic method does not affect rehabilitation outcomes following total knee arthroplasty', Bone and Joint
Journal, vol. 98, no. B11, pp. 89-96. https://doi.org/10.1302/0301-620X.98B9.36250
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.
Download date: 29. Apr. 2020
 1 
Peri-operative analgesic method does not affect rehabilitation outcomes following total 
knee arthroplasty. 
D A McDonald (Prof D, BSc) - Clinical Researcher, Department of Rehabilitation, Golden Jubilee 
National Hospital, Agamemnon St, Clydebank, Scotland, G81 4DY.   
A H Deakin (PhD) – Orthopaedic Audit & Research Manager, Department of Orthopaedics, Golden 
Jubilee National Hospital, Agamemnon St, Clydebank, Scotland, G81 4DY  
B M Ellis (PhD) -  Deputy Director, Graduate School, Glasgow Caledonian University, Cowcaddens 
Road, Glasgow, Scotland, G4 0BA  
Y Robb (PhD) - Lecturer, School of Health & Life Sciences, Glasgow Caledonian University, 
Cowcaddens Road, Glasgow, Scotland, G4 0BA  
T E Howe (PhD) - Professor of Rehabilitation, School of Health & Life Sciences, Glasgow Caledonian 
University, Cowcaddens Road, Glasgow, Scotland, G4 0BA  
A W G Kinninmonth (FRCS) - Consultant Orthopaedic Surgeon Department of Orthopaedics, Golden 
Jubilee National Hospital, Agamemnon St, Clydebank, Scotland, G81 4DY 
N B Scott (FRCA, FRCS) - Consultant Anaesthetist, Department of Anaesthesia, Golden Jubilee 







This non-blinded randomised controlled trial compared the effect of patient controlled epidural 
analgesia (PCEA) versus local infiltration analgesia (LIA) within an established Enhanced 
Recovery Programme on attainment of discharge criteria and recovery at one year following 
surgery. The hypothesis was that LIA would increase the proportion of patients discharged from 
rehabilitation by post-operative day four but not affect outcomes at one year. 242 patients were 
randomized with 109 patients receiving PCEA (mean age 66 SD (11)) and 113 receiving LIA 
(mean age 68 SD (10)). Patients were followed up at six weeks and one year. No difference was 
noted in the proportion of patients discharged from rehabilitation by post-operative day 4, PCEA 
=77% vs. LIA =82% (p=0.33) or mean length of stay (both 4 days, p=0.540).  No difference was 
observed in day of first mobilisation (p= 0.013) or pain scores (P=0.278). At one year follow up 
there were no differences in Oxford Knee Scores (both 41, p=0.915) or complication rates (two 
vs. six, p=0.281). Both techniques provided adequate pain relief, enabled early ambulation and 
accelerated rehabilitation and continued improvement in functional and patient reported 
outcomes up to one year following surgery.  PCEA and LIA enable equitable clinical outcomes 








Enhanced Recovery Programmes (ERP) following total knee arthroplasty (TKA) have 
demonstrated reductions in both morbidity and mortality
1-3
. Their implementation has included 
several major alterations in clinical practice simultaneously and therefore it is difficult to 
ascertain which component(s) of the programme may be most significant in the improvements 
reported
4





, however the optimum method(s) of multimodal analgesia throughout the peri- 
operative period remains unclear
8
. Regional analgesic techniques have demonstrated 
improvements in pain control and outcomes following TKA compared to opioid analgesia 
alone
9,10




and prolonged motor blockade and falls in femoral nerve blocks
12,13 
which may 
hinder early ambulation and delay rehabilitation
13,14
. The effect of these regional analgesic 
techniques on rehabilitation outcomes and long term follow up is poorly understood
9,15
.  
Local Infiltration Analgesia (LIA) has been reported as an alternative analgesic regime with a 
number of studies demonstrating equitable or improved outcomes compared to opioid analgesia
16
 
and other regional anaesthetic techniques
14,17-21
. However due to the varying cocktail of 
infiltration medicines, the volume of infiltrate and limited number of high quality evidence 
studies comparing two regional techniques which allow early ambulation, it is difficult to draw 
comparisons and extrapolate the findings
22
. Furthermore, there is a lack of data from randomised 
 4 
trials looking at long-term follow up.  
The aim of this study was to compare the effect of two regional analgesic techniques, patient 
controlled epidural analgesia (PCEA) versus local infiltration analgesia (LIA) within an 
established Enhanced Recovery Programme to ascertain their impact on attainment of 
rehabilitation discharge criteria and outcomes at six weeks and one-year post-surgery.  
The primary outcome measure was the proportion of patients discharged from rehabilitation on 
post-operative day 4 (POD 4). Secondary outcome measures included in-patient data: verbal 
rated pain scores (VRS); use of additional rescue analgesia; post-operative urinary 
catheterisation rates; ambulation rates on the day of theatre; length of hospital stay; and 
rehabilitation outcomes: Oxford Knee Scores and complication rates at six weeks and one-year 
post-surgery.  
PATIENTS AND METHODS  
The study was a randomised controlled parallel group trial with an equal allocation ratio. Ethical 
approval was obtained from the West of Scotland Research Ethics Committee 
(NRES:09/S10014/56). The study was conducted in accordance with the Declaration of Helsinki 
and conformed to the CONSORT Guidelines
23
 
and has been registered at clinicaltrial.gov 
(NCT02478372). From April 2010-August 2011 patients aged over 18 years undergoing primary 
unilateral TKA for osteoarthritis were considered eligible for inclusion into the study. Exclusion 
criteria included: patients listed for uni-compartmental/bilateral or revision knee surgery, a 
diagnosis of rheumatoid arthritis, coagulation or anatomical defects preventing the use of spinal 
anaesthesia or known allergies to any medications within the trial, inability to give written 
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consent, requiring pre- operative catheterisation for urinary outflow dysfunction and a known 
neurological incident that would limit or make impossible early mobilisation following surgery. 
Written and informed consent for the trial was obtained on the day prior to surgery. Participation 
within the trial ended following the routine one-year follow-up appointment.  
A simple unrestricted (non-block) randomisation method was used to generate the random 
allocation sequence. Patients were randomised to either patient controlled epidural analgesia 
(PCEA) or local infiltration analgesia (LIA). Randomisation was carried out using sequentially 
numbered opaque sealed envelopes
24
. Once written informed consent was obtained by the 
surgeon, the anaesthetist in charge of the patient’s care collected the next numbered envelope on 
the morning of surgery.  
All patients received standardised peri-operative care. This included pre-operative education in 
the form of written information, an education class and exercise DVD. All patients received the 
pre- operative and post-operative analgesic regime in Table 1. Surgery was performed under 
spinal via the L2/3 or L3/4 interspaces using 2.5ml hyperbaric bupivacaine 5 mg.ml-1 
supplemented by a target-controlled infusion of propofol to maintain sedation. In the event of a 
general anaesthesia being required because of failed spinal anaesthesia, the patient was excluded 
from the trial. Tranexamic acid (2.5 g) was administered intravenously to minimise post-
operative blood loss. A medial parapatellar or lateral parapatellar arthrotomy under tourniquet 
was used as per surgeon preference. Cemented implants were as per surgeon preference 
(Triathlon, Stryker, Michigan, USA or Columbus, BBraun Medical Ltd. Melsungen, 
Germany).  
The PCEA group had a catheter sited between L1 and L3 pre-operatively. They received 4ml of 
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2.5 mg.ml-1 levobupivacaine at the end of surgery prior to leaving the operating room. 
Thereafter they self-medicated with 2ml of 1.25 mg.ml-1 bupivacaine via a Patient Controlled 
Epidural Analgesia (PCEA) system (BodyGuard Colourvision 545 Epidural Infusion Pump 
(CME Medical UK Limited, Blackpool, UK)) with a lockout of 15 minutes until 8 a.m. the 
following morning (post-operative day one) when it was stopped. Nurse-administered rescue top-
ups of 4ml of 2.5 mg.ml-1 levobupivacaine were available for inadequate analgesia.  
The LIA group received standardised intra-articular and subcutaneous infiltration during surgery 
using a total of 200 ml of 2mg.ml-1 ropivacaine (Naropin®, AstraZeneca, Sweden) without 
adrenaline or additives
3
. 50ml was injected following bone preparation parallel to the posterior 
femur through the posterior joint capsule in even 10ml aliquots. 30ml was inserted through the 
skin proximal to the suprapatellar pouch down to the level of the femur. 100ml was spread 
around the subcutaneous tissues including the collateral ligaments and cruciate ligaments (when 
preserved) and fatty and connective tissue on the anterior aspect of the incision. A 16-gauge 
epidural catheter (BBraun Medical Ltd. Melsungen, Germany) was inserted via a medial portal 
several centimetres from the wound and passed into the posterior region of the knee. Finally, 
20ml was injected via the catheter following closure of the surgical wound. The catheter was 
then capped off and a bacterial epidural filter applied.  
On return to the ward, patients received nurse-administered boluses of 40ml 2mg.ml-1 
ropivacaine via a BodyGuard 595 Regional Analgesia Infusion Pump (CME Medical UK 
Limited, Blackpool, UK) four hours after leaving theatre, at 22:00 and then at 08:00 on the 
morning of post-operative day one, after which the catheter was removed. In the event of 
uncontrolled pain two additional top ups of 40ml 2mg.ml-1 ropivacaine were prescribed if 
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required within this time frame. All wounds were closed with sutures or clips and standard 
dressings applied
25
Prior to 6pm on the day of theatre, all patients were reviewed by a 




were collected for the first three post-operative days as were daily nausea and 
vomiting scores as per the standard care in our institution at the time.  The usage of PRN 
analgesia, post-operative urinary catheterisation rates and the reason for catheterisation were also 
recorded.  From post-operative day (POD) one patients were reviewed daily by rehabilitation 
staff and were discharged from rehabilitation once they had achieved established standardised 
discharge criteria (Table 2)
3
. Maximum flexion angle achieved at discharge from rehabilitation 
was measured using a hand held goniometer
27
. Patients who were unable to achieve the required 
flexion or demonstrate a return of sufficient quadriceps muscle strength after day five post-
surgery were referred on to outpatient physiotherapy. All patients were discharged directly home.  
Patients attended routine independent arthroplasty follow up clinic appointments at six weeks 
and one year after surgery. Oxford Knee Scores (OKS, 0 to 48 scale)
28
 
and maximum flexion 
were recorded. Any adverse events whilst patients were in hospital following surgery were 
recorded. Transfusion policy was a haemoglobin of <= 8g/dL or if significant symptoms of 
anaemia developed. Information Services Division (ISD) NHS Scotland, provided complication 
data based on readmission to any hospital in Scotland.   up to one-year post surgery. They also 
provided mortality data. 
Statistics  
Preliminary data demonstrated that 49% patients (22/45) receiving PCEA could be discharged 
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from rehabilitation by POD 4 compared to 75% (40/53) who had LIA. Therefore, to achieve a 
90% power at a 1% significance level with 50% discharged in PCEA group and 75% in the LIA 
group it was calculated that the study would require 110 patients in each arm. Allowing for a 
10% fall out rate, it was intended to recruit 121 patients into each arm of the study. Due to the 
large number of secondary outcome measures statistical significance was set at p<0.01.  
Statistical analysis was performed using SSPS version 19 (SPSS Inc., Chicago, IL, USA). Data 
were analysed on a per protocol basis. The primary outcome for the study was assessed using a 
Chi- squared test. The secondary outcomes of length of stay, post-operative mobilisation and 
post- operative catheterisation were assessed using a Chi-squared test. Pain scores, use of PRN 
analgesia, maximal flexion at discharge and follow up along with OKS were not normally 
distributed so were assessed with a Mann-Whitney test. Due to the small numbers of 
complication data, a Fishers Exact Test was used.  
RESULTS  
308 patients attending the outpatient appointment were assessed for eligibility to the trial (Figure 
1). A total of 242 patients were recruited and randomised to the two groups (121 patients per 
group). Demographic data for all randomised patients were similar between groups (Table 3). 
Twenty patients were excluded from the analysis, 12 in the PCEA group and eight in the LIA 
group, all due to failed spinal anaesthesia.  
For the PCEA (n=109) and LIA (n=113) groups no difference was observed between the 
proportions of patients discharged from rehabilitation by POD 4 p=0.332 (Table 4, Figure 2). No 
differences in the time (days) to achieve the discharge criteria, length of hospital stay, pain VRS, 
the PRN analgesia usage or incidence of nausea and vomiting, maximum knee flexion on 
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discharge or proportion of patients sent for further outpatient physiotherapy were seen (Table 4). 
One patient within each group required a PCA morphine pump to be started due to poor pain 
control on post-operative day one.  
A higher proportion of patients within the LIA group were able to ambulate for the first time on 
the afternoon of theatre however this was not statistically significant based on our a-priori 
criterion of p<0.01 (Table 4). All patients within the LIA group had ambulated within 24 hours 
of surgery but four patients within the PCEA group did not achieve this until the morning of 
post-operative day two. The main reason for failed ambulation on theatre day was an unresolved 
spinal anaesthesia block resulting in motor weakness preventing safe ambulation.  
At six weeks and one year follow up no statistically significant difference were observed in 
outcomes (Table 5). Up to one-year post-operation the PCEA group had two complications (one 
wash-out for suspected infection and one acute myocardial infarction) and the LIA group had six 
(one gastro-intestinal bleed, two suspected infections, one renal failure, two deaths (causes 









This study demonstrated no differences between the proportion of patients obtaining set 
discharge criteria by POD 4 following a primary TKA within an established Enhanced Recovery 
Programme whether PCEA (77.1%) or LIA (82.3%) analgesia was used. Similarly, the median 
time to attain discharge criteria (3 days) and total post-operative stay (4 days) showed no 
difference between groups. These findings are contrary to two previous randomised trials of 
continuous epidural and LIA following TKA
14, 29
. Although the time to attain discharge criteria 
for the LIA groups was similar to our trial, the times within the epidural groups was much 
greater (5.5 and 4 days respectfully vs. 3 in our study). In both previous studies the epidural 
regimes were in-situ for 48 hours and had a continuous background infusion of between 4- 10 
ml/hr running delaying early ambulation and commencement of rehabilitation post-surgery. 
Within the present trial the PCEA regime had no background rate infusion and was stopped on 
the morning of post-operative day one at 8a.m. To our knowledge this is the first trial to utilise a 
PCEA regime with no background infusion that enabled early safe ambulation and 
commencement of rehabilitation and provided a greater comparator technique to the LIA than 
previous trial designs. Two recent trials compared PCEA +FNB versus LIA
19,20 
and report a 
similar timeframe to attainment of discharge criteria for both groups within their trial and the 
current trial (3.2 days each). However, due to limited detail of the specific method including 
volume and timing of the PCEA +FNB under investigation, it is difficult to compare these results 
to the PCEA method and findings within the current trial.  
Both PCEA and LIA techniques provided good analgesia comparable to that achieved following 
femoral nerve block for the first 24 and 48-hour period following surgery
17,19,21
. We have 
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demonstrated equitable pain control and outcomes using only local anaesthetic with no additives 
compared to other randomised trials comparing LIA and continuous epidural regimes with 
additives included (i.e. +/- morphine, NSAIDS, steroids and epinephrine)
14,29,30
. The 
extrapolation from this is that  these additives may be unnecessary for either infiltration or 
epidural administration and raises further questions around the benefits of the numerous cocktails 
used
31
. However, to confirm this other trials directly comparing regimes are required. 
The use of LIA boluses following the large volume infiltration in theatre was facilitated via an 
indwelling catheter until the morning (8a.m.) of post-operative day one. Several literature 
reviews suggest that there is insufficient evidence for catheters following large volume injection 
in theatre
22,32
. However recent studies support our findings that there does appear to be further 








improving satisfaction with pain control
36
 
whilst shortening length of hospital stay following 
TKA
3
. No statistical difference was noted between the two groups in the proportion of patients 
ambulated on theatre day or within 24 hour following surgery. The main reasons for delays in 
ambulation on theatre day were a dense bilateral residual motor blockade from the spinal 
anaesthetic or that the patient had not returned from theatre. No incidence of transient peroneal 
nerve palsy was observed within the LIA group compared to other studies which report an 




The changes in OKS over the 12-month period (PCEA=24(-20-38) vs. LIA=22(-3-40), p=0.640) 
suggests an above average predicted improvement compared to published literature (predicted 
improvement in score= 18.4 (9.5)) 
28
. The improvement in score is also better than previous 
published data from our hospital
3
. The reason for this is difficult to ascertain as no fundamental 
changes were made to the Enhanced Recovery Programme.  
Of major concern with the use of the LIA technique and specifically an indwelling catheter is the 
risk of infection 
37
. Although two patients were recorded as having a wound infection with one 
patient returning to theatre for a lavage, no difference was observed between groups (p=1.000). 
The reported incidence (1.7%) of wound infection with the use of a wound catheter is the same 
(1.7%) as a large cohort series (n=1081) from the same hospital
3
 
and considerably lower than 
rates (11%) reported by a recent trial from Scandinavia
38
. No deaths within 30 days of surgery 
were recorded within either group. Two deaths were recorded at one-year post-surgery within the 
LIA group, the cause of death was unknown. It is unlikely these were related directly to the 
surgical intervention or methods of analgesia under investigation within this trial. These findings 
support the efficacy and safety of both techniques however as this study was not powered 
specifically to look at complications, further large-scale cohort studies specifically powered to 
look at each adverse incident in more detail with the use of these techniques are required. 
As with all randomised controlled trials this study has some limitations. It was not blinded which 
may have introduced some reporting bias. A large number of surgeons (n=11) were involved in 
the recruitment and consenting of patients and as a result, a large cohort of eligible patients were 
not approached during the pre-operative assessment clinics. To conform to the ethical 
 13 
submission and trial protocol, only patients who had been identified by the Consultant surgeon, 
were eligible for inclusion within the current study. This could have introduced performance bias 
into the patients included within the study cohort. However, trial demographics for each group 




representative of the standard population attending for TKA surgery within Scotland
39
. In 
addition, the exclusion criteria mean that this trial did not include the whole TKA population. 
There are a minority of patients who cannot have a spinal anaesthetic for clinical reasons and the 
results of this study cannot be applied to this group. Similarly, we excluded those requiring pre-
operative catheterisation as we wished to accurately identify the need for post-operative 
catheterisation in each group and with particular reference to the epidural group. Therefore, it is 
not known whether these results would be seen in these patients. However this study was more 
inclusive than previously reported trials
14,29
. A further limitation is that the time for which 
patients received analgesia would vary dependent on where they were on the theatre list. This 
was true for both groups. However, both groups had similar distributions of positions on the list 
so we do not feel this affected the results in terms of differences between the groups. Further 
work is required to ascertain how much difference the position on the list makes to analgesia 
efficacy. The fact that the study data did not conform to the preliminary data used for the power 
calculation means that the small differences seen in the primary outcome were not significant. 
This current study demonstrates why conclusions on small sample sizes should not be drawn. 
The preliminary data was collected during the introduction of the PCEA as compared to a 
traditional continuous epidural with a background rate limiting ambulation which had been 
standard care within our institution.  The potential learning curve of staff in mobilising patients 
early with epidurals may have contributed to the preliminary data and resultant power 
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calculation.  
This randomised control trial demonstrates that the methods of patient controlled peri-operative 
regional analgesia, PCEA and LIA, used within the current trial do not affect the time taken to 
reach standardised discharge criteria within an established Enhanced Recovery Programme. Both 
techniques provided adequate pain relief and enabled early ambulation and accelerated 
rehabilitation and continued improvement in functional and patient reported outcomes up to one 
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Table 1 Peri-operative Analgesia Regimen 
Time Multimodal Analgesic Regime 
Oral pre-medication  
(2 h before surgery) 
10–20 mg Temazepam 
150mg Ranatidine 
10 mg Dexamethasone 
300 mg Gabapentin 
1 g Paracetamol 
 
Post-operative 300 mg Gabapentin twice daily for 5 days 
1 g Paracetamol 4 times daily 
400 mg Ibuprofen 3 times daily 
10 mg Oxycontin® 12 hourly for 3 doses 

















Table 2. Standardised Rehabilitation Discharge Criteria 
 
Standardised Discharge Criteria 
Independent  (able to dress and personal care) 
Ability to transfer independently on/off bed/chair/toilet/stairs 
80° flexion of the operated knee joint 




















Table 3: Demographic data of all randomised patients and patients excluded following 























 Randomised Patients 
Patients excluded following 
randomisation 





N 121 121 12 8 
Age  66 (11) 68 (10) 67 (13) 70 (10) 
BMI  31 (8) 31 (8) 35 (9) 30 (5) 
Gender – Males 46% 41% 36% 33% 
Operative side – Left 50% 58% 63% 66% 
Pre-Operative OKS  17 17   
ASA 1  11% 18% 0 12.5% 
ASA
 
2 67% 66% 75% 75% 
ASA  3 22% 15% 25% 12.5% 
ASA 4 0% 1% 0 0 
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D/C from rehabilitation by POD 4 
§
  77% 82% 0.332 
Days to D/C  from rehabilitation
 ‡
 3 [1-20] 3 [1-8] 0.755 
Length of stay (days) 
‡
 4 [2-20]  4 [2-12] 0.554 
Post-Op Urinary Catheterisation (%)
§
 9.2% 4.4% 0.159 
Verbal Rating pain Score (VRS)    
VRS POD 0
‡
 3 (4) 3 (4) 0.278 
VRS POD 1
‡
 3 (3) 4 (3) 0.041 
VRS POD 2
‡
 3 (2) 4 (3) 0.319 
Oxynorm usage (10mg Dose)    
POD 1
 ‡
 1 [0-6] 1 [0-5] 0.896 
POD 2 
‡
 2 [0-7] 2 [0-9] 0.336 
POD 3
 ‡
 1 [0-6] 0 [0-5] 0.773 
Total usage 
‡
  4 [0-15]  4 [0-15] 0.554 
Post-Op Nausea and Vomiting  16% 14%  
Proportion of patients ambulating (Cumulative %)     
Theatre Day 
§
 35% 51% 0.013 
 POD 1
§
 96% 100% 0.040 
> 24 hours post-surgery 100% 100%  
Position on Theatre List 
§
   0.300 
1
st
 31% 30%  
2
nd
 32% 36%  
3
rd
 26% 24%  
4
th
 10% 9%  
5
th 
 5% 0%  
Post-operative blood transfusion (n) 0 0  
D/C Maximum Flexion Angle 
 ‡
 80° [60-100] 80° [65-105] 0.795 
Outpatient Physiotherapy referrals on  D/C 18% 19%  
D/C=discharge, POD=Post-operative day, 
‡
Mann Whitney test  
§


























95° [50 to 120°] 
n=113 




32 [7 to 47] 
n=112 




103° [65 to 130°] 
n=105 






41 [14 to 48] 
n=104 
41 [6 to 48] 
0.915 
Change in OKS 
from pre-op 
n=92 
24 [-20 to 38] 
n=98 
22 [-3 to 40] 
0.640 
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Figure 2. Proportion of patients discharged from Rehabilitation per post-operative day 
